Abstract
Epstein-Barr virus (EBV), a member of the herpes group of viruses, is the cause of heterophil-positive infectious mononucleosis, of most heterophil-negative cases, and of occasional cases of tonsillitis and pharyngitis in childhood. Rarely, it may involve the liver or central nervous system as primary manifestations. This virus is also implicated as having a causal relationship to African Burkitt lymphoma and to nasopharyngeal cancer. High antibody titers are present in 30–40% of cases of Hodgkin disease, in some patients with sarcoidosis, and in systemic lupus erythematosus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andiman, W., Gradoville, L., Heston, L., Neydorff, R., Savage, M. E., Kitchingman, G., Shedd, D., and Miller, G., Use of cloned probes to detect Epstein—Barr viral DNA in tissues of patients with neoplastic and lympho-proliferative diseases,J. Infect. Dis. 148: 967 – 977 (1983).
Armstrong, D., Henle, G., and Henle, W., Complement-fixation tests with cell lines derived from Burkitt’s lymphoma and acute leukemias,J. Bacteriol. 91: 1257 – 1262 (1966).
Armstrong, J. A., Evans, A. S., Rao, N., and Ho, M., Viral infections in renal transplant recipients,Infect. Immun. 14: 970 – 975 (1976).
Bailey, G. H., and Raffel. S., Hemolytic antibodies for sheep and ox erythrocytes in infectious mononucleosis,J. Clin. Invest. 14: 228 – 244 (1935).
Ballow, M., Seeley, J., Purtilo, D. T., Onge, S. S., Sakamoto, K., and Rickles, F. R., Familial chronic mononucleosis,Ann. Intern. Med. 97: 821 – 825 (1982).
Banatvala, J. E., Best, J. M., and Waller, D. K., Epstein—Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, and nasopharyngeal carcinoma,Lancet 1: 1205 – 1208 (1972).
Bang, J., Forsoeg paa at overfoere mononucleosis infectiosa til mennesket,Ugeshkr. Laeg. 105: 499 – 504 (1943).
Bar, R. S., DeLor, J., Clausen, K. P., Hurtubise, P., Henle, W., and Hewetson, J. F., Fatal infectious mononucleosis in a family,N. Engl. J. Med. 290: 363 – 367 (1974).
Barondess, J. A., and Erle, H., Serum alkaline phosphatase activity in hepatitis of infectious mononucleosis,Am. J. Med. 29: 43 – 54 (1960).
Bauscher, J. C., and Smith, R. T., Studies of Epstein—Barr virus-host-relationship: Autochthonous and allogeneic lymphocyte stimulation by lymphoblast cell lines in mixed cell culture,Clin. Immunol. Immunopathol. 1: 270 – 281 (1973).
Beale, A. J., Epstein—Barr virus. Dream or reality of a vaccine,Nature 318: 230 (1985).
Bender, C. E., Interpretation of hematologic and serologic findings in the diagnosis of infectious mononucleosis,Ann. Intern. Med. 49: 852 – 865 (1958).
Bender, C. E., Recurrent mononucleosis,J.A.M.A. 182: 954 – 956 (1962).
Bentzon, J. W., The effect of certain infectious diseases on tuberculin allergy,Tubercle 34: 34 – 41 (1953).
Berkel, A. I., Henle, W., Henle, G., Klein, G., Ersoy, F., and Sanal, O., Epstein—Barr virus related antibody patterns in ataxia-telangiectasia,Clin. Exp. Immunol. 35: 196 – 201 (1979).
Biggar, R. J., Henle, W., Fleischer, G., Böcker, J., Lennette, E. T., and Henle, G., Primary Epstein—Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection,Int. J. Cancer 22: 239 – 243 (1978).
Biggar, R. J., Henle, G., Böcker, J., Lennette, E. T., Fleischer, G., and Henle, W., Primary Epstein—Barr virus infections in African infants. II. Clinical and serological observations during seroconversion,Int. J. Cancer 22: 244 – 250 (1978).
Black, F. L., Hierholzer, W. J., Pinheiro, DeP., Evans, A. S., Woodall, J. P., Opton, E. M., Emmons, J. E., West, B. S., Edsall, G., Downs, W. G., and Wallace, D., Evidence for persistence of infectious agents in isolated human populations,Am. J. Epidemiol. 100: 230 – 250 (1974).
Bloedorn, W. A., and Houghton, J. E., The occurrence of abnormal leukocytes in the blood in acute infections,Arch. Intern. Med. 27: 315 – 325 (1921).
Boon, W. H., Mui, C. L. Y., and Too, M., Infectious mononucleosis in Singapore,J. Singapore Pediatr. Soc. 19: 153 – 161 (1977).
Brown, J. W., Clifford, J. E., Sims, J. L., and White, E., Liver function during infectious mononucleosis,Am. J. Med. 6: 321 – 328 (1949).
Cabot, R. C., The lymphocytosis of infection,Am. J. Med. Sci. 145: 335 – 339 (1913).
Carlson, G. W., Brooks, E. H., and Marshall, V. G., Acute glandular fever: Recent epidemic, report of cases,Wis. Med. J. 25: 176 – 178 (1926).
Carter, R. L., and Penman, H. G., The early history of infectious mononucleosis and its relation to “glandular fever,” in:Infectious Mononucleosis (R. L. Carter and H. G. Penman, eds.), pp. 1–18, Blackwell, Oxford, 1969.
Carvalho, R. P. S., Evans, A. S., Frost, P., Dalldorf, G., Camargo, M. E., and Jarma, M., EBV infection in Brazil. I. Occurrence in normal persons, in lymphomas and in leukemias,Int. J. Cancer 11:191–201 (1973).
Centers for Disease Control, Infectious Mononucleosis Surveillance, November 1972.
Centers for Disease Control, Annual Summary 1983,Morbid. Mortal. Week. Rep. 32: 1 – 125 (1984).
Chang, R. S., and Golden, H. D., Transformation of human leukocytes by throat washings from infectious mononucleosis patients,Nature 234: 359 – 360 (1971).
Chang, R. S., Lewis, J. P., and Abildgaard, C. F., Excretors of leucocyte-transforming agents among a human population,N. Engl. J. Med. 289: 1328 – 1329 (1973).
Christine, B. W., Infectious mononucleosis,Conn. Health Bull. 82:115–119(1968).
Corev, L., Stamm, W. E., Feorino, P. M., Bryan, J. A., Weseley, S., Gregg, M. B., and Solangi, K., HBsAG-negative hepatitis in a hemodialysis unit: Relation to Epstein—Barr virus,N. Engl. J. Med. 293: 1273 – 1278 (1975).
Cross, J. G., Conditions simulating an acute leukemia (acute benign leukemia),Minn. Med. 5: 579 – 581 (1922).
Dambaugh, T., Hennessy, K., Chamnankit, L., and Kieff, E., U2 region of Epstein—Barr virus DNA may encode Epstein—Barr nuclear antigen 2.Proc. Natl. Acad. Sci. U.S.A. 81: 7632 – 7636 (1984).
Davidsohn, I., Heterophile antibodies in serum sickness,J. Immunol. 16: 259 – 273 (1929).
Davidsohn, I., and Walker, P. H., The nature of the heterophilic antibodies in infectious mononucleosis,Am. J. Clin. Pathol. 5: 455 – 465 (1935).
Davidsohn, R. J. L., A survey of infectious mononucleosis in the North-East Regional Hospital Board area of Scotland, 1960–9,J. Hyg. 68: 393 – 400 (1970).
DeSchryver, A., Klein, G., Hewetson, J., Rocchi, A., Henle, G., Henle, W., and Pope, J., Comparison of neutralization tests based on abortive infection or transformation of lymphoid culls and their relation to membrane reactive antibodies (Anti-MA),Int. J. Cancer 13: 353 – 362 (1974).
DeSchryver, A., Rosen, A., Gunven, P., and Klein, G., Comparison between two antibody populations in the EBV system: Anti-MA versus neutralizing antibody activity,Int. J. Cancer 17: 8 – 13 (1976).
Diehl, V., Henle, G., Henle, W., and Kohn, G., Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis,J. Virol. 2: 663 – 669 (1968).
Dillner, J., Kallin, B., Ehlin-Henriksson, B., Timar, L., and Klein, G., Characterization of a second Epstein—Barr virus-determined nuclear antigen associated with theBamHI-WYH region of EBV-DNA,Int. J. Cancer 35: 359 – 366 (1985).
Dillner, J., Kallin, B., Klein, G., Jörnvall, H., Alexander, H., and Lerner, R., Antibodies against synthetic peptides react with the second Epstein—Barr virus–associated nuclear antigen,EMBO J1813 – 1818 (1985).
Dillner, J., Sternås, K., Kallin, B., Alexander, H., Ehlin-Henriksson, B., Jörnvall, H., Klein, G., and Lerner, R., Antibodies against a synthetic peptide identify the Epstein—Barr virus-determined nuclear antigen,Proc. Natl. Acad. Sci. U.S.A. 81: 4652 – 4656 (1984).
Dingle, J. H., Badger, G. F., and Jordan, W. S., Jr.,Illness in the Home: A Study of25,000 Illnesses in a Group of Cleveland Families, The Press of Western Reserve, Cleveland, 1964.
Downey, H., and McKinlay, C. A., Acute lymphadenosis compared with acute lymphatic leukemia,Arch. Intern. Med. 32: 82 – 112 (1923).
DuBois, R. E., Seeley, J. K., Brus, I., Sakamoto, K., Ballow, M., Harada, S., Bechtold, T. A., Pearson, G., and Purtilo, D. T., Chronic mononucleosis syndrome,South. Med. J. 77: 1376 – 1382 (1984).
Edwards, J. M. B., and McSwiggan, D. A., Studies on the diagnostic value of an immunofluorescence test for EB virus specific IgM,Clin. Pathol. 27: 647 – 651 (1974).
Edwards, J. M. B., Vandervelde, E. M., Cohen, B. J., and McSwiggan, D. A., Laboratory diagnosis of EB virus infection in some cases presenting as hepatitis,J. Clin. Pathol. 31: 179 – 182 (1978).
Ellenbogen, C., and Reinarz, J. A., The Epstein—Barr virus and its relationship to infectious mononucleosis in Air Force recruits,Milit. Med. 140: 371 – 373 (1974).
Enberg, R. N., Eberle, B. J., and Williams, R. C., Peripheral blood T and B cells in infectious mononucleosis, J. Infect. Dis.130: 104 – 111 (1974).
Epstein, M. A., Epstein—Barr virus—Is it time to develop a vaccine program?J. Natl. Cancer Inst. 56: 697 – 700 (1976).
Epstein, M. A., Vaccination against Epstein—Barr virus: Current progress and future strategies,Lancet 1: 1425 – 1427 (1986).
Epstein, M. A., and Achong, B. G., Various forms of Epstein—Barr virus infection in man: Established facts and a general concept,Lancet 2: 836 – 839 (1973).
Epstein, M. A., and Achong, B. G., Pathogenesis of infectious mononucleosis,Lancet 2: 1270 – 1278 (1977).
Epstein, M. A., Achong, B. G., and Barr, Y. M., Virus particles in cultured lymphoblasts from Burkitt’s lymphoma,Lancet 1: 702 – 703 (1964).
Epstein, M. A., Morgan, A. J., Finerty, S., Randle, B. J., and Kirkwood, J. K., Protection of cottontop tamarins against Epstein—Barr virus-induced malignant lymphoma by a prototype subunit vaccine,Nature 318: 287 – 289 (1985).
Evans, A. S., Experimental attempts to transmit infectious mononucleosis to man,Yale J. Biol. Med. 20: 19 – 26 (1947).
Evans, A. S., Liver function tests in infectious mononucleosis,J. Clin. Invest. 27: 106 – 110 (1948).
Evans, A. S., Further experimental attempts to transmit infectious mononucleosis to man,J. Clin. Invest. 29: 508 – 512 (1950).
Evans, A. S., Infectious mononucleosis in University of Wisconsin students: Report of a five-year investigation,Am. J. Hyg. 71: 342 – 362 (1960).
Evans, A. S., Infectious mononucleosis: Observations from a public health laboratory,Yale J. Biol. Med. 34:261–276 (1961/1962).
Evans, A. S., Complications of infectious mononucleosis: Recognition and management,Hosp. Med 3:24–25, 28 – 33 (1967).
Evans, A. S., Infectious mononucleosis: Recent developments,Gen. Pract. 60: 127 – 134 (1969).
Evans, A. S., Infectious mononucleosis in the armed forces,Milit. Med. 135: 300 – 304 (1970).
Evans, A. S., New discoveries in infectious mononucleosis,Mod. Med. 1: 18 – 24 (1974).
Evans, A. S., The history of infectious mononucleosis,Am. J. Med. Sci. 267: 189 – 195 (1974).
Evans, A. S., Commentary—EB virus, infectious mononucleosis and cancer: The closing of the web,Yale J. Biol. Med. 47:113–122(1974).
Evans, A. S., Infectious mononucleosis and related syndromes,Am. J. Med. Sci. 276: 325 – 339 (1978).
Evans, A. S., Epidemiology of Epstein—Barr virus infection and disease, in:The Human Herpesvirus(A. J. Nahmias, W. Doudle, and R. Schinazi, eds.), pp. 172–183, Elsevier North-Holland, 1982.
Evans, A. S., Discussion of some recent developments in the molecular epidemiology of Epstein—Barr virus infections,Yale J. Biol. Med. 60:317–319(1987).
Evans, A. S., and Campos, L. E., Acute respiratory diseases in students at the University of the Philippines,Bull. WHO 45: 103 – 112 (1971).
Evans, A. S., and Comstock, G. W., Presence of elevated antibody titers to Epstein—Barr virus before Hodgkin’s disease,Lancet 1: 1183 – 1186 (1981).
Evans, A. S., Evans, B. K., and Sturtz, V., Standards for hepatic and hematologic tests in monkeys: Observations during experiments with hepatitis and mononucleosis,Proc. Soc. Exp. Biol. Med. 82: 437 – 440 (1953).
Evans, A. S., and Gutensohn, N. M., A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin‘s disease and their siblings,Int. J. Cancer 34:149–157(1984).
Evans, A. S., and Niederman, J. C., EBV-IgA and new heterophile antibody tests in diagnosis of infectious mononucleosis,Am. J. Clin. Pathol. 77: 555 – 560 (1982).
Evans, A. S., Niederman, J. C., Cenabre, L. C., West, B., and Richards, V. A., A prospective evaluation of heterophile and Epstein—Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody,J. Infect. Dis. 132: 546 – 554 (1975).
Evans, A. S., Niederman, J. C., and McCollum, R. W., Seroepidemiological studies of infectious mononucleosis with EB virus,N. Engl. J. Med. 279: 1121 – 1127 (1968).
Evans, A. S., and Paul, J. R., Infectious mononucleosis, in:Preventive Medicine in World War II, Vol. V:Communicable Diseases(J. B. Coates, Jr., ed.), pp. 355 – 361, Office of the Surgeon General, Department of the Army, Washington, 1960.
Evans, A. S., and Robinton, E. D., An epidemiologic study of infectious mononucleosis in a New England college,N. Engl. J. Med. 242: 492 – 496 (1950).
Evans, A. S., Wanat, J., and Niederman, J. C., Failure to demonstrate concomitant antibody changes to viral antigens other than Epstein—Barr virus (EB V) during or after infectious mononucleosis,Yale J. Biol. Med. 56: 203 – 209 (1983).
Filatov, N. F.,Lektuse ob Ostrikh Infektsion nikh Lolienzynak [Lecture on Acute Infectious Diseases of Children]U. Deitel, Moscow, 1885; cited by P. J. Wising,Acta Med. Scand. [Suppl.] 133: 1 – 102 (1942).
Filatov, N. F.,Semiotik and Diagnotik de Kinderkrankheiten, Verlag von Ferdinand Enke, Stuttgart, 1892.
Fischer, D. K., Robert, M. F., Shedd, D., Summers, W. P., Robinson, J. E., Walak, J., Stefano, J., and Miller, G., Identification of Epstein—Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9 kilobase pair subfragment of the genome,Proc. Natl. Acad. Sci. U.S.A. 81: 43 – 47 (1984).
Fleischer, G. R., and Bolognese, R., Persistent Epstein—Barr virus infection and pregnancy,J. Infect. Dis. 147: 982 – 986 (1983).
Fleischer, G., Lennette, E. T., Henle, G., and Henle, W., Incidence of heterophile antibody responses in children with infectious mononucleosis,J. Pediatr. 94: 723 – 728 (1979).
Gardner, H. T., and Paul, J. R., Infectious mononucleosis at the New Haven Hospital, 1921–46,Yale J. Biol. Med. 19: 839 – 853 (1947).
Gerber, P., and Deal, D. R., Epstein—Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures,Proc. Soc. Exp. Biol. Med. 134: 748 – 751 (1970).
Gerber, P., Nkrumah, F. K., Pritchett, R., and Kieff, E., Comparative studies of Epstein—Barr virus strains from Ghana and the United States,Int. J. Cancer 17: 71 – 81 (1976).
Gerber, P., Purcell, R. H., Rosenblum, E. N., and Walsh, J. H., Association of EB-virus infection with the post-perfusion syndrome,Lancet 1: 593 – 596 (1969).
Gerber, P., and Rosenblum, E. N., The incidence of complement-fixing antibodies to herpes simplex and herpes-like viruses in man and rhesus monkeys,Proc. Soc. Exp. Biol. Med. 128: 541 – 546 (1968).
Gerber, R., Goldstein, L. I., Lucas, S., Nonoyama, M., and Perlin, E., Oral excretion of Epstein—Barr viruses by healthy subjects and patients with infectious mononucleosis,Lancet 2: 988 – 989 (1972).
Gergely, L., Klein, G., and Ernberg, I., Appearance of Epstein—Barr virus-associated antigens in infected Raji cells,Virology 45: 10 – 21 (1971).
Ginsburg, C. M., Henle, W., Henle, G., and Horwitz, C. A., Infectious mononucleosis in children: Evaluation of Epstein—Barr virus specific serological data,J.A.M.A. 237: 781 – 785 (1977).
Ginsburg, C. M., Henle, G., and Henle, W., An outbreak of infectious mononucleosis among the personnel of an outpatient clinic,Am. J. Epidemiol. 104: 571 – 575 (1976).
Giulano, V. J., Jasin, H. E., and Ziff, M., The nature of the atypical lymphocyte in infectious mononucleosis,Clin. Immunol. Immunopathol. 3: 90 – 98 (1974).
Grace, J. T., Blakeslee, J., and Jones, R., Induction of infectious mononucleosis in man by the herpes-type virus (HTV) in Burkitt lymphoma cells in tissue culture,Proc. Am. Assoc. Cancer Res. 10: 31 (1969).
Graves, S., Jr., Recurrent infectious mononucleosis,J. Ky. Med. Assoc. 1: 790 – 793 (1970).
Greenspan, J. S., Greenspan, D., Lennette, E. T., Abrams, D. I., Conant, M. A., Peterson, V., and Freese, V. K., Replication of Epstein—Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-associated lesion,N. Engl. J. Med. 313: 1564 – 1571 (1985).
Grogan, E. A., Summers, W. P., Dowling, S., Shedd, D., Gradoville, L., and Miller, G., Two Epstein—Barr viral nuclear neoantigens distinguished by gene transfer, serology and chromosome binding,Proc. Natl. Acad. Sci. U.S.A. 80: 7650 – 7653 (1983).
Grose, C., Henle, W., Henle, G., and Feorino, P. M., Primary Epstein—Barr infections in acute neurologic disease,N. Engl. J. Med. 292: 392 – 393 (1975).
Haider, S., Coutinho, M. D., and Emond, R. T. D., Tuberculin anergy and infectious mononucleosis,Lancet 2: 74 (1973).
Hainebach, J., II, Beitrag zur Aetiologie des Pfeiffer’ schen Driisenfiebers,Dtsch. Med. Wochenschr. 26: 419 – 420 (1899).
Halchrow, J. P. A., Owen, L. M., and Roger, N. O., Infectious mononucleosis with an account of an epidemic in M.S. Hospital,Br. Med. J. 2: 443 – 447 (1943).
Hallee, T. J., Evans, A. S., Niederman, J. C., Brooks, C. M., and Voegtly, J. H., Infectious mononucleosis at the U.S. Military Academy: A prospective study of a single class over four years,Yale J. Biol. Med. 47: 182 – 195 (1974).
Hamilton, J. K., Sullivan, J. L., Maurer, H. S., Cruzi, F. G., Proirson, A. J., Stenke, K., Finkelstein, G. Z., Landing, B., Grunnet, M., and Purtilo, D. T., X-linked lymphoproliferative syndrome registry report,J. Pediatr. 4: 669 – 673 (1980).
Hampar, B., Hsu, K. C., Martos, L. M., and Walker, J. L., Serologic evidence that a herpes-type virus is the etiologic agent of heterophile-positive infectious mononucleosis,Proc. Natl. Acad. Sci. U.S.A.68: 1407 – 1411 (1971).
Hanshaw, J. B., Niederman, J. C., and Chessin, L. N., Cytomegalovirus macroglobulin in cell associated herpes virus infections,J. Infect. Dis. 125: 304 – 306 (1972).
Hardy, D. A., and Steel, C. M., Cytotoxic potential of lymphocytes stimulated with autochthonous lymphoid cell lines,Experientia 27: 1336 – 1338 (1971).
Haynes, B. F., Schooley, R. T., Grouse, J. E., Playing-Wright, C. R., Dolin, R., and Fauci, A. S., Characterization of thymus-derived lymphocyte subsets in acute Epstein—Barr virus induced infectious mononucleosis,J. Immunol. 122: 699 – 702 (1979).
Haynes, B. F., Schooley, R. T., Playing-Wright, C. R., Grouse, J. E., Dolin, R., and Fauci, A. S., Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein—Barr-virus-induced infectious mononucleosis,J. Immunol. 123: 2095 – 2101 (1979).
Heath, C. W., Brodsky, A. L., and Potolsky, A. I., Infectious mononucleosis in a general population,Am. J. Epidemiol. 95: 46 – 52 (1972).
Henderson, E., Heston, L., Grogan, E., and Miller, G., Radiobiological inactivation of Epstein—Barr virus,J. Virol. 25: 51 – 59 (1978).
Henderson, E., Miller, G. Robinson, J., and Heston, L., Efficiency of transformation of lymphocytes by Epstein—Barr virus,Virology 76: 152 – 163 (1977).
Henke, C. E., Kurland, L. T., and Elveback, L. R., Infectious mononucleosis in Rochester, Minn., 1950 through 1969,Am. J. Epidemiol. 98: 483 – 490 (1973).
Henle, G., and Henle, W., Immunofluorescence in cells derived from Burkitt’s lymphoma,J. Bacteriol. 91: 1248 – 1256 (1966).
Henle, G., and Henle, W., Observations on childhood infections with Epstein—Barr virus,J. Infect. Dis. 121: 303 – 310 (1970).
Henle, G., Henle, W., and Diehl, V., Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis,Proc. Natl. Acad. Sci. U.S.A. 59: 94 – 101 (1968).
Henle, G., Henle, W., and Horwitz, C. A., Antibodies to Epstein—Barr virus-associated nuclear antigen in infectious mononucleosis,J. Infect. Dis. 130: 231 – 239 (1974).
Henle, W., and Klein, G., Demonstration of two distinct components in the early antigen complex of Epstein—Barr virus-infected cells,Int. J. Cancer 8: 272 – 282 (1971).
Henle, W., and Henle, G., Epstein—Barr virus-specific serology in immunologically compromised individuals,Cancer Res 41: 4222 – 4225 (1981).
Henle, W., Henle, G., Andersson, J., Ernbern, I., Klein, G., Horwitz, C. A., Marklund, G., Rymo, L., Wellinder, C., and Straus, S. E., Antibody responses to Epstein—Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein—Barr virus infection,Proc. Natl. Acad. Sci., U.S.A. 84: 570 – 574 (1987).
Henle, W., Henle, G., and Horwitz, C. A., Epstein—Barr virus specific diagnostic tests in infectious mononucleosis,Hum. Pathol. 5: 551 – 565 (1974).
Henle, W., Henle, G., Harrison, F. S., Joyner, C. R., Klemola, E., Paloheimo, J., Scriba, M., and Von Essen, F., Antibody responses to the Epstein—Barr virus and cytomegaloviruses after open-heart and other surgery,N. Engl. J. Med. 282: 1068 – 1074 (1968).
Henle, W., Henle, G., Niederman, J. C., Haltia, K., and Klemola, E., Antibodies to early antigens induced by Epstein—Barr virus in infectious mononucleosis,J. Infect. Dis. 124: 58 – 67 (1971).
Henle, W., Henle, G., Pearson, G., Scriba, M., Waubke, R., and Zajac, B. A., Differential reactivity of human serums with early antigens induced by Epstein—Barr virus,Science 169: 188 – 190 (1970).
Hennessy, K., Fennewald, S., and Kieff, E., A third viral nuclear protein in lymphoblasts immortalized by Epstein—Barr virus,Proc. Natl. Acad. Sci. U.S.A. 82: 6300 – 6304 (1985).
Hennessy, K., Heller, M., Van Saulteri, V., and Kieff, E., Simple repeat array in Epstein—Barr virus DNA encodes that of the Epstein—Barr nuclear antigen,Science 220: 1396 – 1398 (1983).
Hennessy, K., and Kieff, E., A second nuclear protein is encoded by Epstein—Barr virus in latent infection,Science 227: 1238 – 1240, (1985).
Hewetson, J. F., Rochi, G., Henle, W., and Henle, G., Neutralizing antibodies to Epstein—Barr virus in healthy populations and patients with infectious mononucleosis,J. Infect. Dis. 128: 283 – 389 (1973).
Ho, M., Miller, G., Atchison, R. W., Breinig, M. K., Dummer, J. S., Andiman, W., Starzl, T. E., Eastman, R., Griffith, P. B., Hardesty, R. L., Bahnson, H. T., and Rosenthal, J. T., Epstein—Barr virus infections and DNA hybridization studies in post-transplantation lymphoma and lymphoproliferative lesions. The role of primary infection,J. Infect. Dis. 152: 876 – 885 (1985).
Hoagland, R. J., The transmission of infectious mononucleosis,Am. J. Med. Sci. 229: 262 – 272 (1955).
Hoagland, R. J., Resurgent heterophil-antibody reaction after infectious mononucleosis,N. Engl. J. Med. 269: 1307 – 1308 (1963).
Hoagland, R. J., The incubation period of infectious mononucleosis,Am. J. Public Health 54: 1699 – 1705 (1964).
Hoagland, R.,Infectious Mononucleosis, Grune & Stratton, New York, 1967.
Hobson, F. G., Lawson, B., and Wigfield, M., Glandular fever, a field study,Br. Med. J. 1: 845 – 852 (1958).
Horwitz, C. A., Henle, W., Henle, G., Rudnick, H., and Latts, E., Long-term serological follow-up of patients for Epstein—Barr virus after recovery from infectious mononucleosis,J. Infect. Dis. 151: 1150 – 1153 (1985).
Hoskins, T. W., Fletcher, W. B., Blake, J. M., Pereira, M.S., and Edwards, J. M. B., EB virus antibody and infectious mononucleosis in a boarding school for boys,J. Clin. Pathol. 29: 42 – 45 (1976).
Hsu, J. F., Evans, A. S., Niederman, J. C., and Cenabre, L. C., An enzyme-linked immunosorbant assay (ELISA) for measurement of heterophile antibody,Yale J. Biol. Med. 55: 429 – 436 (1982).
Hutt, L. M., Huang, Y. T., Dascomb, H. E., and Pagano, J. S., Enhanced destruction of lymphoid cell lines by peripheral blood leucocytes taken from patients with acute infectious mononucleosis,J. Immunol. 115: 243 – 248 (1975).
Isaacs, R., Chronic infectious mononucleosis,Blood 3: 858 – 861 (1948).
Jennings, E.,Prevalence of EB Virus Antibody in Hawaii, M.D. Thesis, Yale University School of Medicine, New Haven, 1973.
Joncas, J., and Mitnyan, C., Serological response of the EB V antibodies in pediatric cases of infectious mononucleosis and in their contacts,Can. Med. Assoc. J. 102: 1260 – 1263 (1970).
Jondal, M., and Klein, G., Surface markers on human B and T lymphocytes. II. Presence of Epstein—Barr virus receptors on B lymphocytes,J. Exp. Med. 138: 1365 – 1378 (1973).
Jondal, M., Klein, G., Oldstone, M. B. S., Bokish, V., and Yefenof, E., Surface markers on human B and T lymphocytes. VII. Association between complement and Epstein—Barr virus receptors on human lymphoid lines,Scand. J. Immunol. 5: 401 – 410 (1976).
Jones, J. F., Ray, C. G., Minnich, L. L., Hicks, M. J., Kibler, R., and Lucas, D. O., Evidence for active Epstein—Barr virus infection in patients with persistent unexplained illnesses: Elevated anti-early antigen antibodies,Ann. Intern. Med. 102: 1 – 7 (1985).
Jordan, W. S., and Albright, R. W., Liver function tests in infectious mononucleosis,J. Lab. Clin. Med. 35: 688 – 698 (1950).
Junge, U., Deinhardt, F., and Hoekstra, J., Stimulation of peripheral lymphocytes by allogeneic and autochthonous mononucleosis lymphocyte cell lines,J. Immunol. 106: 1306 – 1315 (1971).
Kano, K., and Milgrom, F., Heterophile antigens and antibodies in medicine,Curr. Top. Microbiol. Immunol. 77: 43 – 69 (1977).
Kasl, S. V., Evans, A. S., and Niederman, J. C., Psychosocial risk factors in the development of infectious mononucleosis,Psychosom. Med. 41: 445 – 466 (1979).
Kaufman, R. E., Recurrences in infectious mononucleosis,Am. Pract. 1: 673 – 676 (1950).
Kibler, R., Lucas, D. O., Hicks, M. J., Poulos, B. T., and Jones, J. F., Immune function in chronic active Epstein—Barr virus infection,J. Clin. Immunol. 5: 46 – 54 (1985).
Klein, G., Diehl, V., Henle, G., Henle, W., Pearson, G., and Niederman, J. C., Relations between Epstein—Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. II. Comparison of cells and sera from patients with Burkitt’s lymphoma and infectious mononucleosis,J. Exp. Med. 128: 1021 – 1030 (1968).
Klein, G., Klein, E., Clifford, P., and Sternsward, G., Search for tumor specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction,Proc. Natl. Acad. Sci. U.S.A. 55: 1628 – 1635 (1966).
Klein, G., Lindahl, T., Jondal, M., Leibolb, W., Menézes, J., Nilsson, K., and Sundström, C., Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived) lacking the Epstein—Barr virus genome and derived from three human lymphomas,Proc. Natl. Acad. Sci. U.S.A. 71: 3283 – 3286 (1974).
Klein, G., Svedmyr, E., Jondal, M., and Persson, P. O., EBV-determined nuclear antigen (EBNA) -positive cells in the peripheral blood of infectious mononucleosis patients,Int. J. Cancer 17: 21 – 26 (1976).
Klemola, E., Henle, G., Henle, W., and Von Essen, R., Infectious mononucleosis-like disease with negative heterophile agglutination test: Clinical features in relation to Epstein—Barr virus and cytomegalovirus antibodies,J. Infect. Dis. 121: 608 – 614 (1970).
Lang, D. J., and Hanshaw, J. B., Cytomegalovirus infection and the postperfusion syndrome: Recognition of primary infection in four patients,N. Engl. J. Med. 280: 1145 – 1149 (1969).
Lee, C. L., Davidsohn, I., and Slaby, R., Horse agglutinins in infectious mononucleosis,Am. J. Clin. Pathol. 49: 3 – 11 (1968).
Lehane, D. E., A seroepidemiologic study of infectious mononucleosis: The development of EB virus antibody in a military population,J.A.M.A. 212: 2240 – 2242 (1970).
Lemon, S. M., Hutt, L. M., Huang, Y., Blum, J., and Pagano, J. H., Simultaneous infection with multiple herpesviruses,J.A.M.A. 66: 270 – 276 (1979).
Lemon, S. M., Hutt, L. M., Shaw, J. C., Li, J. H., and Pagano, J. H., Replication of EBV in epithelial cells during infectious mononucleosis,Nature 268: 268 – 270 (1977).
Lennette, E. T., Henle, G., Henle, W., and Horowitz, C. A., Heterophil antigen in bovine sera detectable by immune adherence hemagglutination with infectious mononucleosis sera,Infect. Immun. 19: 923 – 927 (1978).
Liebowitz, S.,Infectious Mononucleosis, Grune & Stratton, New York, 1953.
Longcope, W. T., Infectious mononucleosis (glandular fever), with a report of ten cases,Am. J. Med. Sci. 164: 781 – 807 (1922).
Mangi, R., Niederman, J. C., Kelleher, J. E., Dwyer, J. M., Evans, A. S., and Kantor, F. S., Depression of cell-mediated immunity during acute infectious mononucleosis,N. Engl. J. Med. 291: 1149 – 1153 (1974).
Mason, K. L., An ox cell hemolysin test for the diagnosis of infectious mononucleosis,J. Hyg. 49: 471 – 481 (1951).
Maurer, B. A., Imamura, T., and Wilbert, S. M., Incidence of EB virus containing cells in primary and secondary clones of several Burkitt lymphoma cell lines,Cancer Res 30: 2870 – 2875 (1970).
Miller, G., The oncogenicity of Epstein—Barr virus,J. Infect. Dis. 130: 187 – 205 (1974).
Miller, G., Biology of Epstein—Barr virus, in:Viral Oncology(G. Klein, ed.) pp. 713 – 738, Raven Press, New York, 1980.
Miller, G., Grogan, E. A., Fischer, D. K., Niederman, J. C., Schooley, R. T., Henle, W., Lenoir, G., and Liu, C., Antibody responses to two Epstein—Barr virus nuclear antigens defined by gene transfer,N. Engl. J. Med. 312: 750 – 756 (1985).
Miller, G., Grogan, E., Rowe, D., Rooney, C., Heston, L., Eastman, R., Andiman, W., Niederman, J., Lenoir, G., Henle, W., Sullivan, J., Schooley, R., Vossen, J., Stauss, S., and Issekutz, T., Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein—Barr virus infection,J. Infect. Dis. 156: 26 – 35 (1987).
Miller, G., and Heston, L., Expression of Epstein—Barr viral capsid, complement fixing and nuclear antigens in stationary and exponential phase cultures,Yale J. Biol. Med. 47: 123 – 135 (1974).
Miller, G., Katz, B. Z., and Niederman, J. C., Some recent developments in the molecular epidemiology of Epstein—Barr virus infections,Yale J. Biol. Med. 60: 307 – 316 (1986).
Miller, G., and Lipman, M., Release of infectious Epstein—Barr virus by transformed marmoset leucocytes,Proc. Natl. Acad. Sci. U.S.A. 70: 190 – 194 (1973).
Miller, G., Miller, M. H., and Stitt, D., Epstein—Barr viral antigen in single cell clones of two human leucocytic lines,J. Virol. 6: 699 – 701 (1970).
Miller, G., Niederman, J. C., and Andrews, L. L., Prolonged oropharyngeal excretion of Epstein—Barr virus after infectious mononucleosis,N. Engl. J. Med. 288: 229 – 232 (1973).
Miller, G., Niederman, J. C., and Stitt, D. A., Infectious mononucleosis: Appearance of neutralizing antibody to Epstein—Barr virus measured by inhibition of formation of lymphoblastoid cell lines,J. Infect. Dis. 125: 403 – 406 (1972).
Miller, G., Robinson, J., Heston, L., and Lipman, M., Differences between laboratory strains of Epstein—Barr virus based on immortalization, abortive infection and interference,Proc. Natl. Acad. Sci. U.S.A. 71: 4006 – 4010 (1974).
Moir, J. I., Glandular fever in the Falkland Islands,Br. Med. J. 2: 822 – 823 (1930).
Morgan, D. G., Niederman, J. C., Miller, G., Smith, H. W., and Dowaliby, J. M., Site of Epstein—Barr virus replication in the oropharynx,Lancet 2: 1154 – 1157 (1979).
Mori, T., Kano, K., and Milgrom, F., Formation of Paul Bunnell antibodies by cultures of lymphocytes from infectious mononucleosis,Cell Immunol 34: 289 – 298 (1977).
Morse, P. F., Glandular fever,J.A.M.A. 77: 1403 – 1404 (1921).
Munoz, N., Davidson, R. J. K., Witthoff, B., Ericsson, J. E., and De The, G., Infectious mononucleosis and Hodgkin’s disease,Int. J. Cancer 22: 10 – 13 (1978).
Newall, K. W., The reported incidence of glandular fever, and analysis of a report of the Public Health Laboratory Service,J. Clin. Pathol. 10: 20 – 22 (1957).
Niederman, J. C., Infectious mononucleosis at the Yale-New Haven Medical Center, 1946–1955,Yale J. Biol. Med. 28: 629 – 643 (1956).
Niederman, J. C., Chronicity of Epstein—Barr virus infection,Ann. Int. Med. 102: 119 – 121 (1985).
Niederman, J. C., Evans, A. S., McCollum, R. W., and Subrahmanyan, L., Prevalence, incidence and persistence of EB virus antibody in young adults,N. Engl. J. Med. 282: 361 – 365 (1970).
Niederman, J. C., McCollum, R. W., Henle, G., and Henle, W., Infectious mononucleosis: Clinical manifestations in relation to EB virus antibodies,J.A.M.A. 203: 20 – 209 (1968).
Niederman, J. C., and Miller, G., Kinetics of the antibody response toBamHI-K nuclear antigen in uncomplicated infectious mononucleosis,J. Infect. Dis. 154: 346 – 349 (1986).
Niederman, J. C., Miller, G., Pearson, H. A., Pagano, J. S., and Dowaliby, J. M., Infectious mononucleosis: EB virus shedding in saliva and the oropharynx,N. Engl. J. Med. 294: 1355 – 1359 (1976).
Niederman, J. C., and Scott, R. B., Studies on infectious mononucleosis: Attempts to transmit the disease to human volunteers,Yale J. Biol. Med. 38: 1 – 10 (1965).
Nikoskelainen, J. J., Ablashi, D. V., Isenberg, R. A., Neel, E. U., Miller, R. G., and Stevens, D. A., Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein—Barr virus antigens and correlation with clinical and hematologic parameters,J. Immunol. 121: 1239 – 1244 (1978).
Nikoskelainen, J., Leikola, J., and Klemola, E., IgM antibodies specific for Epstein—Barr virus in infectious mononucleosis without heterophile antibodies,Br. Med. J. 4: 72 – 75 (1974).
Nonoyama, M., and Pagano, J. S., Homology between Epstein—Barr virus DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics,Nature 242: 44 – 47 (1973).
North, J. R., Morgan, A. J., Thompson, J. L., and Epstein, M. A., Purified EB virusM R340,000 glycoprotein induces potent virus–neutralizing antibodies when incorporated in liposomes,Proc. Natl. Acad. Sci. U.S.A. 79: 7504 – 7508 (1982).
Old, L. J., Clifford, P., Boyse, E. A., DeHarven, E., Geering, G., Oettgen, H. F., and Williamson, B., Precipitating antibody in human serum to an antigen present in cultured Burkitt lymphoma cells,Proc. Natl. Acad. Sci. U.S.A. 56: 1699 – 1704 (1966).
Pagano, J. S., The Epstein—Barr viral genome and its interactions with human lymphoblastoid cells and chromosomes, in:Viruses, Evolution and Cancer(K. Maramorosch and E. Kurstak, eds.), pp. 79 – 116, Academic Press, New York, 1974.
Pannuti, C. S., Carvalho, R. P. S., Evans, A. S., Cenabre, L. C., Neto, A., Camargo, M., Angelo, J. J. P., and Takimoto, S., A prospective clinical study of the mononucleosis syndrome in a developing country,Int. J. Epidemiol. 9: 349 – 353 (1980).
Pattengale, P. K., Gerber, P., and Smith, R. W., Selective transformation of B lymphocytes by EB virus,Lancet 2: 1153 – 1155 (1973).
Pattengale, P. K., Gerber, P., and Smith, R. W., B–cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein—Barr virus,J. Natl. Cancer Inst. 52: 1081 – 1086 (1974).
Pattengale, P. K., Smith, R. W., and Perlin, E., Atypical lymphocytes in acute infectious mononucleosis,N. Engl. J. Med. 291:1145–1148.
Paul, J. R., and Bunnell, W. W., The presence of heterophile antibodies in infectious mononucleosis,Am. J. Med. Sci. 183: 91 – 104 (1932).
Paul, O., Mononucleosis on board a destroyer,U.S. Naval Med. Bull. 44: 614 – 617 (1945).
Pearson, G., Dewey, F., Klein, G., Henle, G., and Henle, W., Relation between neutralization of Epstein—Barr virus and antibodies to cell membrane antigens induced by the virus,J. Natl. Cancer Inst. 45: 989 – 995 (1970).
Pearson, G., Henle, G., and Henle, W., Production of antigens associated with Epstein—Barr virus in experimentally infected lymphoblastoid cell lines,J. Natl. Cancer Inst. 46: 1243 – 1250 (1971).
Pereira, M. S., Blake, J. M., and MacCrae, A. D., EB virus antibody at different ages,Br. Med. J. 4: 526 – 527 (1969).
Pereira, M. S., Field, A. M., Blake, J. M., Rodgers, F. G., Bailey, L. A., and Davies, J. R., Evidence for oral excretion of EB virus in infectious mononucleosis,Lancet 1: 710 – 711 (1972).
Pfeiffer, E., Driisenfieber,Jahrb. Kinderheilkd 29: 257 – 264 (1889).
Pope, J. H., Horne, M. K., and Wetters, E. J., Significance of a complement-fixing antigen associated with herpes-like virus and detected in the Raji cell line,Nature 228: 186 – 187 (1969).
Pulvertaft, R. J. X., Cytology of Burkitt’s tumor (African lymphoma),Lancet 1: 238 – 240 (1964).
Purtilo, D. T., Bhawan, J., Hutt, L. M., DeNicola, L., Szymanski, I., Yang, J. P. S., Boto, W., Maier, R., and Thorley-Lawson, D., Epstein—Barr virus infection in the X-linked recessive lymphoproliferative syndrome,Lancet 1: 798 – 801 (1978).
Purtilo, D. T., Hutt, L., Bhawan, J., Yang, J. P. S., Cassel, C., Allegro, S., and Rosen, F. S., Immunodeficiency to the Epstein—Barr virus in the X-linked recessive lymphoproliferative syndrome, Clin. Immunol.Immunopathol 9: 147 – 156 (1978).
Qualtiere, L. F., and Pearson, G. R., Solubilization of Epstein—Barr virus induced membrane antigen by limited papain digestion,Fed. Proc. 37: 1817 (1978).
Reedman, B. M., and Klein, G., Cellular localization of an Epstein—Barr virus (EB V) associated complement-fixing antigen in producer and non–producer lymphoblastoid cell lines,Int. J. Cancer 11: 499 – 520 (1973).
Rickinson, A. B., Crawford, D., and Epstein, M. A., Inhibition of thein vitrooutgrowth of Epstein—Barr virus transformed lymphocytes by thymus dependent lymphocytes from infectious mononucleosis patients,Clin. Exp. Immunol. 28: 72 (1977).
Robinson, J. E., Brown, N., Andiman, W., Halliday, K., Francke, U., Robert, M. F., Andersson-Anvret, M., Horstmann, D. M., and Miller, G., Diffuse polyclonal B-cell lymphoma during primary infection with Epstein—Barr virus,N. Engl. J. Med. 320: 1293 – 1296 (1980).
Robinson, J., and Miller, G., Assay for Epstein—Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood,J. Virol. 15: 1065 – 1072 (1975).
Robinson, J., Smith, D., and Niederman, J. C., Plasmacytic differentiation of circulating Epstein—Barr virus-infected B lymphocytes during acute infectious mononucleosis,J. Exp. Med. 153: 235 – 244 (1981).
Robinson, J., Smith, D., and Niederman, J. C., Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis,Nature 287: 334 – 335 (1981).
Rocchi, G., DeFelici, A., Ragona, G., and Heinz, A., Quantitative evaluation of Epstein—Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis,N. Engl. J. Med. 296: 132 – 134 (1977).
Rocchi, G., Hewetson, J., and Henle, W., Specific neutralizing antibodies in Epstein—Barr virus associated diseases,Int. J. Cancer 11: 637 – 647 (1973).
Rosalki, S. B., Lwynn, J. T., and Verney, P. T., Transaminase and liver function studies in infectious mononucleosis,Br. Med. J. 1: 929 – 932 (1960).
Rosdahl, N., Larsen, S. O., and Thamdrup, B., Infectious mononucleosis in Denmark: Epidemiological observations based on positive Paul-Bunnell reactions 1940– 1969,Scand. J. Infect. Dis. 5: 163 – 170 (1973).
Rosen, A., Gergely, P., Jondal, M., and Klein, G., Polyclonal Ig production after Epstein—Barr virus infection of human lymphocytesin vitro, Nature 267: 52 (1977).
Rothfield, N. F., Evans, A. S., and Niederman, J. C., Clinical and laboratory aspects of raised virus antibody titers in systemic lupus erythematosus,Ann. Rheum. Dis. 32: 238 – 246 (1973).
Rowe, D., Heston, L., Metlay, J., and Miller, G., Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein—Barr virus which is missing in its non-immortalizing deletion mutant, P3 HRJ-1,Proc. Natl. Acad. Sci. U.S.A. 82: 7429 – 7433 (1985).
Royston, I., Sullivan, J. L., Periman, P. O., and Perlin, E., Cell-mediated immunity to Epstein—Barr virus-transformed lymphoblastoid cells in acute infectious mononucleosis,N. Engl. J. Med. 293: 1159 – 1163 (1975).
Sakamoto, K., Freed, H., and Purtilo, D., Antibody responses to Epstein—Barr virus in families with the X-linked lymphoproliferative syndrome,J. Immunol. 125: 921 – 925 (1980).
Sawyer, R. N., Evans, A. S., Niederman, J. C., and McCollum, R. W., Prospective studies of a group of Yale University freshmen. I. Occurrence of infectious mononucleosis,J. Infect. Dis. 123: 263 – 269 (1971).
Schiller, J., and Davey, F. R., Human leukocyte locus A HL-A antigens and infectious mononucleosis,Am. J. Clin. Pathol. 62: 325 – 328 (1974).
Schmitz, H., and Scherer, M., IgM antibodies to Epstein—Barr virus in infectious mononucleosis,Arch. Ges. Vi rusforsch. 37: 332 – 339 (1972).
Sculley, T. B., Walker, P. J., Moss, D. J., and Pope, J. H., Identification of multiple Epstein—Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis,J. Virol. 52: 89 – 93 (1984).
Sheldon, P. J., Hemsted, E. H., Holborow, E. J., and Papamichael, M., Thymic origin of atypical lymphocytes in infectious mononucleosis,Lancet 2: 1153 – 1155 (1973).
Shope, T., and Miller, G., Epstein—Barr virus, heterophile responses in squirrel monkeys inoculated with virus-transformed autologous leucocytes,J. Exp. Med. 137: 140 – 147 (1973).
Sixby, J. W., Lemon, S. M., and Pagano, J. S., A second site for Epstein—Barr virus shedding: The uterine cervix,Lancet 11: 1122 – 1124 (1986).
Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., and Pagano, J. S., Epstein—Barr virus replication in oropharyngeal epithelial cells,N. Engl. J. Med. 310: 1225 – 1230 (1984).
Smith, H., and Denman, A. M., A new manifestation of infection with Epstein—Barr virus,Br. Med. J. 2: 248 – 249 (1978).
Sohier, R.,La Mononucleose Infectieuse, Masson, Paris, 1943.
Sohier, R., Lepine, P., and Sautter, V., Recherches sur la transmission experimental de la mononucleose au singe et a l’homme,Ann. Inst. Pasteur 65: 50 – 62 (1940).
Sprunt, T. P., and Evans, F. A., Mononuclear leukocytosis in reaction to acute infections (in infectious mononucleosis),Bull. Johns Hopkins Hosp. 31: 410 – 417 (1920).
Steel, C. M., and Ling, N. R., Immunopathology of infectious mononucleosis,Lancet 2: 861 – 862 (1973).
Stevenson, E. M. K., and Brown, T. G., Infectious mononucleosis: Preliminary investigation of a series of cases,Glasgow Med. J. 140: 139 – 150 (1943).
Storrie, M. D., Sawyer, R. N., Sphar, R. L., and Evans, A. S., Seroepidemiological studies of Polaris submarine crews. II. Infectious mononucleosis,Milit. Med. 141: 30 – 33 (1976).
Strauch, B., Andrews, L., Miller, G., and Siegel, N., Oropharyngeal excretion of Epstein—Barr virus by renal transplant recipients and other patients treated with immunosuppressant drugs,Lancet 1: 234 – 237 (1974).
Straus, S. E., Tosato, G., Armstrong, G., Lawley, T., Preble, O. T., Henle, W., Davey, R., Pearson, G., Epstein, J., Brus, I., and Blaese, R. M., Persisting illness and fatigue in adults with evidence of Epstein—Barr virus infection, Ann. Intern. Med.102: 7 – 16 (1985).
Ström, J., Infectious mononucleosis—Is the incidence increasing?Acta Med. Scand. 168:35–39(1960).
Sumaya, C. V., Primary Epstein—Barr virus infections in children,Pediatrics 59: 16 – 21 (1977).
Summers, W. P., Grogan, E. A., Shedd, D., Robert, M., Liu, C., and Miller, G., Stable expression in mouse cells of nuclear neoantigen following transfer of a 3.4 megadalton cloned fragment of Epstein—Barr virus DNA,Proc. Natl. Acad. Sci. U.S.A. 79: 5688 – 5692 (1982).
Symposium, Chronic Epstein—Barr Virus Disease: A workshop held by the National Institute of Allergy and Infectious Diseases,Ann. Intern. Med. 103: 951 – 953 (1985).
Taylor, A. W., Effects of glandular fever in acute leukemia,Br. Med. J. 1: 589 – 593 (1953).
Thomsen, S.,Studier over Mononucleosis Infectiosa, Munksgaard, Copenhagen, 1942.
Thorley-Lawson, D. A., Chess, L., and Strominger, J. L., Suppression ofin vitroEpstein—Barr virus infection: A new role for adult human T lymphocytes,J. Exp. Med. 146: 495 – 507 (1977).
Tischendorf, P., Balagtas, R. C., Deinhardt, F., Knospe, W. H., Maynard, J. E., Noble, G. R., and Shramek, G. J., Development and persistence of immunity to Epstein—Barr virus in man.J. Infect. Dis. 122: 401 – 409 (1970).
Tobi, M., Ravid, Z., Morag, A., Chowers, I., Feldman-Weiss, V., Michaeli, Y., Ben-Chetrit, E., Shalit, M., and Knobler, H., Prolonged atypical illness associated with serological evidence of persistent Epstein—Barr virus infection,Lancet 1: 61 – 64 (1982).
Tosato, G., Magrath, I., Koski, I., Dooley, N., and Blaese, M., Activation of suppressor T cells during Epstein—Barr virus induced infectious mononucleosis,N. Engl. J. Med. 301: 1133 – 1137 (1979).
University Health Physicians and P.H.L.S. Laboratories, A joint investigation: Infectious mononucleosis and its relationship to EB virus antibody,Br. Med. J. 4: 643 – 646 (1971).
Vandermeer, R., Lutterloh, C. H., and Pilot, J., Infectious mononucleosis: An analysis of 26 clinical and 340 subclinical cases,Am. J. Med. Sci. 210: 765 – 774 (1945).
Veltri. R. W., McClung, J. E., and Sprinkle, P.M., Epstein—Barr nuclear antigen (EBNA) carrying lymphocytes in human palatine tonsils,J. Gen. Virol. 32: 455 – 460 (1976).
Veltri, R. W., McClung, J. E., and Sprinkle, P. M., EBV antigens in lymphocytes of patients with exudative tonsillitis, infectious mononucleosis and Hodgkin’s disease,Int. J. Cancer 21: 683 – 687 (1978).
Virolainen, M., Anderson, L. C., Lalla, M., and Von Essen, R., T-lymphocyte proliferation in mononucleosis,Clin. Immunol. Immunopathol. 2: 114 – 120 (1973).
Visintine, A. M., Gerber, P., and Nahmias, A. J., Leucocyte transforming agent (Epstein—Barr virus) in newborn infants and older individuals,J. Pediatr. 89: 571 – 575 (1976).
Wahren, B., Espmark, A., Lantorp, K., and Sterner, G., EBV antibodies in family contacts of patients with infectious mononucleosis,Proc. Soc. Exp. Biol. Med 133:934– 939 (1970).
Walters, M. K., and Pope, J. H., Studies of the EB virus-related antigens of human leucocyte cell lines,Int. J. Cancer 8: 32 – 40 (1971).
Wang, P. -S., and Evans, A. S., Prevalence of antibodies to Epstein—Barr virus and cytomegalovirus in sera from a group of children in the the People’s Republic of China,J. Infect. Dis. 153: 150 – 152 (1986).
Wechsler, H. F., Rosenblum, A. H., and Sills, C. T., Infectious mononucleosis: Report of an epidemic in an army post,Ann. Intern. Med 25:113–133, 236 – 265 (1946).
Werner, J., Haff, R. F., Henle, G., Henle, W., and Pinto, C. A., Responses of gibbons to inoculation of Epstein-virus,J. Infect. Dis. 126: 678 – 681 (1972).
West, J. P., An epidemic of glandular fever,Arch. Pediatr. 13: 889 – 900 (1986).
Wising, P. J., A study of infectious mononucleosis (Pfeiffer’s disease) from the etiological point of view,Acta Med. Scand. [Suppl] 133: 1 – 102 (1942).
Wolf, H., Hanss, M., and Wilmes, E., Persistence of Epstein—Barr virus in the parotid gland,J. Virol. 51: 795 – 798 (1983).
Wollner, D., Ueber die serologische Diagnose der infektiosen Mononucleose nach Paul-Bunnell mit nativen and fermentierten Hammel Erythrocytes 2,Immunitaets Forsch 112: 290 – 308 (1955).
Wroblewski, F., Increasing clinical significance of alterations in enzymes in body fluids,Ann. Intern. Med. 50: 62 – 93 (1959).
Yefenof, E., Bakacs, T., Einhorn, L., Ernberg, I., and Klein, G., Epstein—Barr virus (EBV) receptors, complement receptors and EBV infectibility of different lymphocyte fractions of human peripheral blood,Cell Immunol 35: 34 – 42 (1978).
Young, L. S., Clark, D., Sixbey, J. W., and Rickinson, A. B., Epstein—Barr virus receptors on human pharyngeal epithelia,Lancet 1: 240 – 242 (1986).
Zajac, B. A., and Kohn, G., Epstein—Barr virus antigens, marker chromosomes, and interferon production in clones derived from cultured Burkitt tumor cells,J. Natl. Cancer Inst. 45: 399 – 406 (1970).
Zur Hausen, H. H., Clifford, P., Henle, G., Henle, W., Klein, G., Santesson, L., and Schulte-Holthausen, H., EB-virus DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx,Nature 228: 1056 – 1057 (1970).
Zur Hausen, H., Dorreier, K., Egger, H., Schulte-Holthausen, H., and Wolf, H., Attempts to detect virus-specific DNA in human tumors, II. Nucleic acid hybridization with complementary RNA of human herpes group viruses,Int. J. Cancer 13: 657 – 664 (1974).
`
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Publishing Corporation
About this chapter
Cite this chapter
Evans, A.S., Niederman, J.C. (1989). Epstein-Barr Virus. In: Evans, A.S. (eds) Viral Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0705-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0705-1_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8041-5
Online ISBN: 978-1-4613-0705-1
eBook Packages: Springer Book Archive